Cancer Spread Stopped
• arcleina 100 per cent success rate and are now hoping to team up with a pharmaceutical company to develop it for humans. The Research, published in the Journal Molecular Cancer, reveals how Dr Cinzia Allegrucci and Dr Andrew Johnson centres around reacti
